Global Neglected Tropical Disease Treatment Market Report and Forecast 2025-2034

Neglected Tropical Disease Treatment Market Overview

Neglected tropical diseases (NTDs) are treated through a combination of medications, vaccines, and supportive care tailored to the specific disease. Treatments include anti-parasitic drugs, antibiotics, antifungals, and emerging biologics to combat infections caused by bacteria, parasites, and viruses. Vaccines play a preventive role, especially for diseases like dengue and rabies. Supportive measures, including wound care and nutritional supplementation, are essential for recovery and improving patient outcomes. Innovative therapies and combination treatments are increasingly employed to enhance efficacy and minimise drug resistance. Expanding access to treatments in underserved areas remains a priority to reduce the global burden of NTDs.

Neglected Tropical Disease Treatment Market Growth Drivers

Expansion of Global Partnerships Driving Market Growth

Growing investment in research and development and increasing advocacy for neglected tropical diseases (NTDs) are driving the global market forward. For instance, In December  2024, the Global Health Innovative Technology (GHIT) Fund and the World Health Organization (WHO) signed a memorandum of understanding (MoU) to enhance their collaboration in addressing NTDs. Their focus includes advancing research for new treatments and interventions, mobilising resources through an NTD investment toolkit, and raising awareness globally and locally. This strategic partnership is poised to accelerate access to affordable and effective solutions for NTDs. The expanded cooperation will stimulate market growth by improving global health frameworks and encouraging innovation in NTD treatments and vaccines, creating significant market momentum in the forecast period.

Indigenous Vaccine Development Paving Path for Neglected Tropical Disease Treatment Market Value in Developing Countries

Rising government investments and the growing demand for regional solutions are key drivers of the NTD market. For instance, in August  2024, India’s Council of Medical Research (ICMR) and Panacea Biotec launched the first-ever Phase 3 clinical trial for the country’s indigenous tetravalent dengue vaccine. This vaccine, developed to combat all four dengue virus serotypes, is crucial in a country where dengue remains a significant public health challenge. With successful Phase 1 and 2 trials, this initiative is set to transform the market by introducing a locally developed solution. The anticipated approval and availability of this vaccine will catalyse market growth, making the NTD space more robust, with increased attention to vaccine development during the forecast period.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Neglected Tropical Disease Treatment Market Trends

Neglected Tropical Disease Treatment Market Segmentation

Market Breakup by Region

• North America 

• Europe  
• Asia Pacific 
• Latin America 
• Middle East and Africa

Neglected Tropical Disease Treatment Market Share

Dengue to Dominate the Segment by Disease Type

Dengue is likely to hold the largest share of the market by disease type, driven by its widespread prevalence and increasing incidence rates, especially in tropical and subtropical regions. As per the analysis  by Expert Market Research, the global dengue testing market is likely to grow at a CAGR of 4.6% by 2034. The disease’s significant health burden has led to heightened governmental initiatives, research funding, and vaccine development. Additionally, the rising awareness and availability of effective treatment options are accelerating its diagnosis and management. In the forecast period, continued advancements in diagnostic tools, alongside the rollout of novel vaccines, are expected to strengthen dengue's position as the leading segment, driving overall market growth and improving healthcare access globally.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Segment by Treatment to Hold Significant Neglected Tropical Disease Treatment Market Value

Drugs are poised to represent the largest segment in the market by treatment due to their widespread use in combating neglected tropical diseases. Anti-parasitic, antifungal, and antibiotic therapies are crucial for addressing diverse disease types. Rising investments in drug discovery and the development of novel formulations enhance their accessibility and efficacy. The availability of cost-effective generic options further supports their adoption, particularly in low- and middle-income countries. With a growing focus on expanding healthcare infrastructure and improving treatment coverage, the drug segment is set to sustain its dominance and contribute significantly to market expansion during the forecast period.

Neglected Tropical Disease Treatment Market Segmentation by Route of Administration to Witness Growth

Oral administration is likely to dominate the market by route of administration due to its convenience, patient compliance, and cost-effectiveness. This segment benefits from the extensive availability of oral drug formulations, which are easy to distribute and administer, especially in resource-limited settings. Rising innovation in oral drug delivery systems, such as extended-release tablets and combination therapies, further enhances treatment outcomes. In the forecast period, the increasing emphasis on improving access to healthcare in remote regions is expected to reinforce the leadership of oral administration, boosting market growth and ensuring more effective management of neglected tropical diseases.

Hospitals to Lead the Segmentation by End User

Hospitals are expected to hold the largest neglected tropical disease treatment market share by end-user, owing to their comprehensive diagnostic and treatment capabilities. They provide access to advanced technologies, expert medical staff, and specialised care, making them the preferred choice for managing complex cases of neglected tropical diseases. Growing government investments in public health infrastructure and the rising number of patients seeking hospital care are significant drivers for this segment. During the forecast period, hospitals are anticipated to maintain their dominance, supported by ongoing developments in healthcare systems and increased focus on early disease detection and effective treatment protocols.

Hospital Pharmacy to Dominate the Neglected Tropical Disease Treatment Market by Distribution Channel

Hospital pharmacies will likely dominate the market by distribution channel, primarily due to their direct access to patients and the availability of a wide range of essential medications. They play a critical role in ensuring timely and accurate dispensing of drugs, particularly in urgent and severe cases of neglected tropical diseases. The growing integration of electronic prescribing and inventory systems in hospital pharmacies enhances efficiency and accessibility. In the forecast period, hospital pharmacies are expected to retain their leading position, driven by advancements in healthcare delivery models and their pivotal role in supporting comprehensive patient care.

Neglected Tropical Disease Treatment Market Analysis by Region

Asia Pacific is expected to hold the largest market share driven by a high disease burden, particularly in densely populated and low-income regions. Countries like India, Indonesia, and the Philippines report significant cases of diseases such as dengue, leprosy, and soil-transmitted helminthiases. Substantial government initiatives, international aid, and increased healthcare spending enhance access to treatments and diagnostics. Meanwhile, North America and Europe benefit from advanced R&D and funding for neglected disease treatments, although their case numbers are comparatively lower. Latin America, with diseases like Chagas and leishmaniasis, and the Middle East and Africa, heavily affected by sleeping sickness and rabies, also contribute to market growth through regional collaborations and awareness campaigns.

Leading Players in the Neglected Tropical Disease Treatment Market